Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion type Assertion NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_head.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion description "[the accumulation and efflux of Tc-MIBI and Tc-Tfos in the nasopharyngeal carcinoma cell line CNE-1 were examined in the presence or absence of various inhibitors of P-glycoprotein (PGP) and/or multidrug resistance associated protein (MRP) activity [GG918, PSC833, verapamil (Vrp), cyclosporin A (CsA) and buthionine sulfoximine (BSO)].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_provenance.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion evidence source_evidence_literature NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_provenance.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion SIO_000772 11189941 NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_provenance.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion wasDerivedFrom befree-2016 NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_provenance.
- NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_assertion wasGeneratedBy ECO_0000203 NP307743.RAFbzE1T4vsA6D6CRLT7ZxdPiOTkYR4P16v1ajfhSe-yk130_provenance.